4 July 2018 in BMC Pregnancy and Childbirth
Excessive gestational weight gain (GWG) is a potential risk factor for hypertensive disorders of pregnancy (HDP). We systematically reviewed three electronic databases for relevant articles published in English: PubMed, EMBASE and Web of Science. The Newcastle-Ottawa Scale was used to assess study quality. Random-effects meta-analyses were performed to supply a pooled estimation of the OR comparing the risk of HDP among healthy pregnant women with and without excessive GWG. The pooled estimation for the association between excessive GWG and the risk of HDPs yielded an odds ratio (OR) of 1.79 (95% CI: 1.61–1.99). A subgroup analysis showed that women who had excessive GWG were more likely to have an HDP (OR 1.82; 95% CI 1.53–2.17), preeclampsia (OR 1.92; 95% CI 1.36–2.72), or gestational hypertension (OR 1.67; 95% CI 1.43–1.95). The pooled estimation for the association between excessive GWG and the risk of HDPs among pregestational normal weight women yielded an OR of 1.57 (95% CI 1.26–1.96). A subgroup analysis showed that women who had excessive GWG were more likely to have HDP (OR 1.45; 95% CI 1.09–1.92) or gestational hypertension (OR 1.51; 95% CI 1.22–1.86). The summary ORs of pre-gestational underweight women and pre-gestational overweight and obese women were 2.17 (95% CI 1.56–3.02) and 1.32 (95% CI 1.08–1.63), respectively. The findings of this study suggest that excessive GWG in accordance with the IOM recommendations influences the rate of HDP.
14 April 2022 in Analytical Cellular Pathology
Inflammation and hypoxia are involved in numerous cancer progressions. Reportedly, the toll-like receptor 4 (TLR4)/nuclear factor kappa B (NF-κB) pathway and hypoxia-inducible factor-1α (HIF-1α) are activated and closely related to the chemoresistance and poor prognosis of epithelial ovarian cancer (EOC). However, the potential correlation between TLR4/NF-κB and HIF-1α remains largely unknown in EOC. In our study, the possible positive correlation among TLR4, NF-κB, and HIF-1α proteins was investigated in the EOC tissues. Our in vitro results demonstrated that LPS can induce and activate HIF-1α through the TLR4/NF-κB signaling in A2780 and SKOV3 cells. Moreover, hypoxia-induced TLR4 expression and the downstream transcriptional activity of NF-κB were HIF-1α-dependent. The cross talk between the TLR4/NF-κB signaling pathway and HIF-1α was also confirmed in the nude mice xenograft model. Therefore, we first proposed the formation of a TLR4/NF-κB/HIF-1α loop in EOC. The positive feedback loop enhanced the susceptibility and responsiveness to inflammation and hypoxia, which synergistically promote the initiation and progression of EOC. The novel mechanism may act as a future therapeutic candidate for the treatment of EOC.
20 July 2020 in Clinical and Experimental Pharmacology and Physiology
11 April 2025 in Scientific Reports
This study aimed to explore the expression characteristics of miRNAs in cardiovascular diseases (CVD) and depression within a plateau environment, to better understand their potential role in Plateau Psycho-CVD. A prospective study design was employed to analyze circulating small RNAs from 20 subjects using high-throughput sequencing technology. Participants were divided into four groups (C, PPC, PP, PC) for comparative analysis. Differentially expressed miRNAs were selected for further functional enrichment analysis. The findings revealed that hsa-miR-1976 and hsa-miR-4685-3p were significantly upregulated in patients with Plateau Psycho-CVD and mental health issues. These miRNAs were closely associated with key pathways relevant to cardiovascular and mental health, including the PI3K-Akt and neurotrophin signaling pathways. Additionally, the downregulated miRNAs in the PPC group were linked to increased expression of AKT1 and STAT3, genes associated with bipolar disorder and inflammatory pathways, indicating a potential impact on neural function. This study identifies hsa-miR-1976 and hsa-miR-4685-3p as novel biomarkers for plateau stress dual heart disease, with AKT1 and STAT3 emerging as potential therapeutic targets. These insights pave the way for further research and clinical applications in related fields.
30 March 2026 in Pharmacology Research & Perspectives
As living standards improve and the population ages, cardiovascular disease poses a significant threat to human health. Apigenin, a flavonoid compound found in many fruits and vegetables native to warm climates, is named after celery because it is found in the highest concentrations in this plant. Apigenin exhibits various physiological and pharmacological activities. However, its protective effects on the cardiovascular system and the underlying mechanisms are unclear. The aim of this study is to investigate the role of apigenin and its mechanism in protecting against myocardial cell damage induced by OGD/R in H9c2 rat myocardial cells. MTT experiments demonstrated that apigenin protects cells from OGD/R‐induced damage under OGD/R conditions. Molecular mechanism studies showed that apigenin (API) inhibits HIF‐1α protein expression and promotes miR‐20a expression under OGD/R conditions. This reduces the expression of autophagy‐related proteins, inhibits cellular autophagy, and SOD activity. Thus, API exerts a protective effect on cells under OGD/R conditions. These results suggest that apigenin protects cells from oxidative stress damage by inhibiting HIF‐1α expression and promoting miR‐20a expression, thereby reducing autophagy levels in H9c2 cells under OGD/R conditions.